• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯卫生技术评估(HTA)机构的当地专家的期望:研讨会结论。

What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions.

机构信息

Assistant Professor of Pharmacoeconomics and HCPs Behavior Department of Clinical Pharmacy, College of Pharmacy, King Saud University, Riyadh 11451, Saudi Arabia.

Advisor for Health Technology Assessment Initiative, Vision Realization Office, Ministry of Health, Riyadh, Saudi Arabia.

出版信息

Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):99-104. doi: 10.1080/14737167.2019.1610398. Epub 2019 Apr 29.

DOI:10.1080/14737167.2019.1610398
PMID:31032687
Abstract

: Saudi Arabia is undergoing a massive health-care transformation to fulfill its new, national 'Vision 2030.' To align with this objective, Saudi Arabia is establishing a new, independent and evidence-based health technology assessment (HTA) entity to help it maximizes health gains through efficient use of resources. This study was designed to ascertain how local experts perceive the creation of such a national HTA entity in Saudi Arabia; what they think about it and expect from it.: To achieve study aim, we held two workshops in Riyadh, Saudi Arabia, each lasting three and a half hours and each hosted by the Saudi Ministry of Health (MOH). We invited 26 local experts from a variety of professional backgrounds to discuss the establishment of a national HTA entity.: The findings from experts workshops were structured around four axes, namely vision and remit; services provided and technologies covered; process and method; and implementation and practical considerations.: This paper discusses the findings of the local experts convened at the workshops relative to their expectations for and views about a national HTA entity within Saudi Arabia.

摘要

沙特阿拉伯正在进行大规模的医疗保健转型,以实现其新的国家“2030 愿景”。为了实现这一目标,沙特阿拉伯正在建立一个新的、独立的、基于证据的卫生技术评估(HTA)实体,以帮助其通过有效利用资源实现最大的健康收益。本研究旨在确定当地专家如何看待在沙特阿拉伯建立这样一个国家 HTA 实体;他们对此有何看法以及期望从中学到什么。

为了实现研究目的,我们在沙特阿拉伯的利雅得举办了两次研讨会,每次持续三个半小时,每次都由沙特卫生部(MOH)主办。我们邀请了 26 名来自不同专业背景的当地专家,讨论建立一个国家 HTA 实体的问题。

专家研讨会的结果围绕四个方面进行了构建,即愿景和任务;提供的服务和涵盖的技术;过程和方法;以及实施和实际考虑。

本文讨论了在研讨会中召集的当地专家的调查结果,这些结果涉及他们对沙特阿拉伯国家 HTA 实体的期望和看法。

相似文献

1
What local experts expect from a health technology assessment (HTA) entity in Saudi Arabia: workshop conclusions.沙特阿拉伯卫生技术评估(HTA)机构的当地专家的期望:研讨会结论。
Expert Rev Pharmacoecon Outcomes Res. 2020 Feb;20(1):99-104. doi: 10.1080/14737167.2019.1610398. Epub 2019 Apr 29.
2
Pharmaceutical companies' views on a health technology assessment (HTA) entity in Saudi Arabia.制药公司对沙特阿拉伯卫生技术评估(HTA)机构的看法。
Saudi Pharm J. 2020 Jun;28(6):662-668. doi: 10.1016/j.jsps.2020.04.006. Epub 2020 Apr 23.
3
Health technology assessment in Saudi Arabia.沙特阿拉伯的卫生技术评估
Expert Rev Pharmacoecon Outcomes Res. 2018 Aug;18(4):393-402. doi: 10.1080/14737167.2018.1474102. Epub 2018 May 16.
4
Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop.沙特阿拉伯卫生技术评估(HTA)中药品的价值驱动因素:能力建设多利益相关方研讨会的结果
Saudi Pharm J. 2021 Sep;29(9):946-954. doi: 10.1016/j.jsps.2021.08.001. Epub 2021 Aug 4.
5
Transformation of health care and the new model of care in Saudi Arabia: Kingdom's Vision 2030.医疗保健的转型与沙特阿拉伯的新型医疗模式:王国的 2030 愿景。
J Med Life. 2021 May-Jun;14(3):347-354. doi: 10.25122/jml-2021-0070.
6
Practical tools and methods for health technology assessment in Europe: structures, methodologies, and tools developed by the European Network for Health Technology Assessment, EUnetHTA.在欧洲进行卫生技术评估的实用工具和方法:欧洲卫生技术评估网络(EUnetHTA)制定的结构、方法和工具。
Int J Technol Assess Health Care. 2009 Dec;25 Suppl 2:1-8. doi: 10.1017/S0266462309990626.
7
Health technology assessment to optimize health technology utilization: using implementation initiatives and monitoring processes.健康技术评估以优化健康技术的利用:使用实施举措和监测流程。
Int J Technol Assess Health Care. 2010 Jul;26(3):309-16. doi: 10.1017/S0266462310000309.
8
[Quality of health care, accreditation, and health technology assessment in Croatia: role of agency for quality and accreditation in health].克罗地亚的医疗保健质量、认证与卫生技术评估:卫生质量与认证机构的作用
Acta Med Croatica. 2010 Dec;64(5):425-34.
9
Saudi Arabia: A future regional hub for advanced education, research, science and technology.沙特阿拉伯:未来先进教育、研究、科学与技术的区域中心。
J Pak Med Assoc. 2015 Oct;65(10):1112-5.
10
Effects of a team Quality Improvement method in a national clinical audit programme of four clinical specialties in Ministry of Health hospitals in Saudi Arabia.团队质量改进方法在沙特阿拉伯卫生部医院四个临床专科全国临床审计项目中的效果。
Int J Qual Health Care. 2024 Feb 5;36(1). doi: 10.1093/intqhc/mzad107.

引用本文的文献

1
Healthcare systems and health economics in GCC countries: informing decision-makers from the perspective of the Gulf health economics association.海湾合作委员会国家的医疗保健系统与卫生经济学:从海湾卫生经济协会的视角为决策者提供信息
Front Public Health. 2025 Mar 25;13:1510401. doi: 10.3389/fpubh.2025.1510401. eCollection 2025.
2
Access to Medicines and Pharmaceutical Policy in Saudi Arabia: A Scoping Review.沙特阿拉伯的药品获取与制药政策:一项范围综述
Integr Pharm Res Pract. 2023 Jul 15;12:137-155. doi: 10.2147/IPRP.S410262. eCollection 2023.
3
Promise of Real-World Evidence for Patient Centricity in Gulf Cooperation Council Countries: Call to Action.
海湾合作委员会国家以患者为中心的真实世界证据的前景:行动呼吁。
Drugs Real World Outcomes. 2023 Mar;10(1):1-9. doi: 10.1007/s40801-022-00336-0. Epub 2022 Nov 17.
4
Methodological Approaches to Cost-Effectiveness Analysis in Saudi Arabia: What Can We Learn? A Systematic Review.沙特阿拉伯成本效益分析的方法学途径:我们能学到什么?一项系统综述。
MDM Policy Pract. 2022 Mar 21;7(1):23814683221086869. doi: 10.1177/23814683221086869. eCollection 2022 Jan-Jun.
5
Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop.沙特阿拉伯卫生技术评估(HTA)中药品的价值驱动因素:能力建设多利益相关方研讨会的结果
Saudi Pharm J. 2021 Sep;29(9):946-954. doi: 10.1016/j.jsps.2021.08.001. Epub 2021 Aug 4.
6
Improvement initiative in LDL-C management in Saudi Arabia: A call to action.沙特阿拉伯低密度脂蛋白胆固醇管理的改善倡议:行动呼吁。
Int J Cardiol Heart Vasc. 2020 Oct 27;31:100667. doi: 10.1016/j.ijcha.2020.100667. eCollection 2020 Dec.
7
Pharmaceutical companies' views on a health technology assessment (HTA) entity in Saudi Arabia.制药公司对沙特阿拉伯卫生技术评估(HTA)机构的看法。
Saudi Pharm J. 2020 Jun;28(6):662-668. doi: 10.1016/j.jsps.2020.04.006. Epub 2020 Apr 23.